NY
Nilesh Yashwant Gholap
About Nilesh Yashwant Gholap
Data last updated:
Nilesh Yashwant Gholap is a Director at Ojasvi Tradings Private Limited (since 2021) and Designated Partner at Sridatta Pharmaceuticals Llp (since 2025). The companies operate in Trading and Pharma. The largest current company by reported revenue is Ojasvi Tradings Private Limited at ₹1.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Dec 2021 | 2021 | ₹1.17 Cr (FY 2025) | Active | |
| Designated Partner | 12 Dec 2025 | 2025 | Active |
Board colleagues of Nilesh Yashwant Gholap
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alka Yashwant Gholap | 10381379 | Ojasvi Tradings Private Limited | Director |
| Pravin Anil Rakshe | 09438872 | Ojasvi Tradings Private Limited | Director |
| Yashwant Shankar Gholap | 09438870 | Ojasvi Tradings Private Limited | Director |
| Pundlik | 11424867 | Sridatta Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilesh Yashwant Gholap
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilesh Yashwant Gholap
Nilesh Yashwant Gholap currently holds 2 directorships: Ojasvi Tradings Private Limited (Director, since 16 Dec 2021, revenue ₹1.17 Cr (FY 2025)); Sridatta Pharmaceuticals Llp (Designated Partner, since 12 Dec 2025).
Nilesh Yashwant Gholap was first appointed on 16 Dec 2021 as Director at Ojasvi Tradings Private Limited. The most recent appointment on record is 12 Dec 2025 at Sridatta Pharmaceuticals Llp.
The current boards of Nilesh Yashwant Gholap's companies include Alka Yashwant Gholap (Ojasvi Tradings Private Limited), Pravin Anil Rakshe (Ojasvi Tradings Private Limited), Yashwant Shankar Gholap (Ojasvi Tradings Private Limited), Pundlik (Sridatta Pharmaceuticals Llp).